U.S. Capital Wealth Advisors LLC Buys 2,221 Shares of Cardinal Health, Inc. (NYSE:CAH)

U.S. Capital Wealth Advisors LLC raised its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 59.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,959 shares of the company's stock after acquiring an additional 2,221 shares during the quarter. U.S. Capital Wealth Advisors LLC's holdings in Cardinal Health were worth $821,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the company. Cyrus J. Lawrence LLC bought a new position in shares of Cardinal Health during the 4th quarter worth about $26,000. Tompkins Financial Corp raised its holdings in shares of Cardinal Health by 106.7% in the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after acquiring an additional 128 shares during the last quarter. Bellwether Advisors LLC acquired a new stake in shares of Cardinal Health in the 4th quarter worth about $32,000. Lee Danner & Bass Inc. acquired a new stake in shares of Cardinal Health in the 4th quarter worth about $35,000. Finally, Itau Unibanco Holding S.A. acquired a new stake in shares of Cardinal Health in the 4th quarter worth about $36,000. Institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Up 0.5%

CAH traded up $0.73 on Monday, hitting $161.70. The company's stock had a trading volume of 1,408,240 shares, compared to its average volume of 2,238,153. The company's 50 day simple moving average is $157.67 and its 200-day simple moving average is $139.03. The firm has a market cap of $38.59 billion, a P/E ratio of 25.23, a price-to-earnings-growth ratio of 1.59 and a beta of 0.68. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $2.15 by $0.20. The company had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 68.84%. Cardinal Health's revenue for the quarter was up .0% on a year-over-year basis. During the same period last year, the firm earned $2.08 EPS. Equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.26%. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date is Tuesday, July 1st. Cardinal Health's dividend payout ratio (DPR) is presently 31.83%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on CAH shares. Wall Street Zen upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a report on Monday, May 5th. Bank of America upped their target price on shares of Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a report on Tuesday, June 10th. Citigroup restated a "neutral" rating and issued a $170.00 target price (up previously from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Mizuho increased their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research note on Monday, March 31st. Finally, Evercore ISI reiterated an "outperform" rating and issued a $180.00 price objective (up previously from $175.00) on shares of Cardinal Health in a research note on Thursday, June 12th. Three investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $157.43.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.